4//SEC Filing
Lapidus Stanley 4
Accession 0000899243-19-016463
CIK 0001492674other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 6:23 PM ET
Size
9.2 KB
Accession
0000899243-19-016463
Insider Transaction Report
Form 4
Lapidus Stanley
Director
Transactions
- Exercise/Conversion
Common Stock
2019-06-08+9,000→ 62,010 total - Award
Stock Option (Right to Buy)
2019-06-07+22,000→ 22,000 totalExercise: $1.54Exp: 2029-06-07→ Common Stock (22,000 underlying) - Exercise/Conversion
Restricted Stock Units
2019-06-08+9,000→ 9,000 total→ Common Stock (9,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On June 8, 2018 the reporting person was granted 9,000 restricted stock units that vested on June 8, 2019.
- [F3]The stock option vests and becomes exercisable in 12 substantially equal monthly installments commencing June 7, 2019.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001678195
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 6:23 PM ET
- Size
- 9.2 KB